Skip to main content

Fecal Microbiome Among Nursing Home Residents with Advanced Dementia and Clostridium difficile

Digestive Diseases and Sciences volume 63, pages 1525–1531 (2018)Cite this article

Abstract

Background/Objectives

Patients colonized with toxinogenic strains of Clostridium difficile have an increased risk of subsequent infection. Given the potential role of the gut microbiome in increasing the risk of C. difficile colonization, we assessed the diversity and composition of the gut microbiota among long-term care facility (LTCF) residents with advanced dementia colonized with C. difficile.

Design

Retrospective analysis of rectal samples collected during a prospective observational study.

Setting

Thirty-five nursing homes in Boston, Massachusetts.

Participants

Eighty-seven LTCF residents with advanced dementia.

Measurements

Operational taxonomic units were identified using 16S rRNA sequencing. Samples positive for C. difficile were matched to negative controls in a 1:3 ratio and assessed for differences in alpha diversity, beta diversity, and differentially abundant features.

Results

Clostridium difficile sequence variants were identified among 7/87 (8.04%) residents. No patient had evidence of C. difficile infection. Demographic characteristics and antimicrobial exposure were similar between the seven cases and 21 controls. The overall biodiversity among cases and controls was reduced with a median Shannon index of 3.2 (interquartile range 2.7–3.9), with no statistically significant differences between groups. The bacterial community structure was significantly different among residents with C. difficile colonization versus those without and included a predominance of Akkermansia spp., Dermabacter spp., Romboutsia spp., Meiothermus spp., Peptoclostridium spp., and Ruminococcaceae UGC 009.

Conclusion

LTCF residents with advanced dementia have substantial dysbiosis of their gut microbiome. Specific taxa characterized C. difficile colonization status.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. Clostridium difficile infection in 2015. Centers for Disease Control and Prevention (CDC). Available at: https://www.cdc.gov/media/releases/2015/p0225-clostridium-difficile.html. Accessed July 3, 2017.

  2. Antimicrobial resistance. Centers for Disease Control and Prevention (CDC). Available at: https://www.cdc.gov/drugresistance/biggest_threats.html. Accessed July 3, 2017.

  3. Ziakas PD, Joyce N, Zacharioudakis IM, et al. Prevalence and impact of Clostridium difficile infection in elderly residents of long-term care facilities, 2011: a nationwide study. Medicine (Baltimore). 2016;95:e4187.

    Article  Google Scholar 

  4. Karanika S, Grigoras C, Flokas ME, et al. The attributable burden of Clostridium difficile infection to long-term care facilities stay: a Clinical Study. J Am Geriatr Soc. 2017;65:1733–1740.

    Article  PubMed  Google Scholar 

  5. Ziakas PD, Zacharioudakis IM, Zervou FN, et al. Asymptomatic carriers of toxigenic C. difficile in long-term care facilities: a meta-analysis of prevalence and risk factors. PLoS ONE. 2015;10:e0117195.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  6. Vincent C, Manges AR. Antimicrobial use, human gut microbiota and Clostridium difficile colonization and infection. Antibiotics (Basel). 2015;4:230–253.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  7. Theriot CM, Young VB. Interactions between the gastrointestinal microbiome and Clostridium difficile. Annu Rev Microbiol. 2015;69:445–461.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  8. Manges AR, Labbe A, Loo VG, et al. Comparative metagenomic study of alterations to the intestinal microbiota and risk of nosocomial Clostridum difficile-associated disease. J Infect Dis. 2010;202:1877–1884.

    Article  PubMed  Google Scholar 

  9. Vincent C, Stephens DA, Loo VG, et al. Reductions in intestinal Clostridiales precede the development of nosocomial Clostridium difficile infection. Microbiome. 2013;1:18.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Girotra M, Garg S, Anand R, et al. Fecal microbiota transplantation for recurrent Clostridium difficile infection in the elderly: long-Term outcomes and microbiota changes. Dig Dis Sci. 2016;61:3007–3015.

    Article  PubMed  Google Scholar 

  11. Seekatz AM, Aas J, Gessert CE, et al. Recovery of the gut microbiome following fecal microbiota transplantation. MBio. 2014;5:e00893-00814.

    Article  CAS  Google Scholar 

  12. Zacharioudakis IM, Zervou FN, Pliakos EE, et al. Colonization with toxinogenic C. difficile upon hospital admission, and risk of infection: a systematic review and meta-analysis. Am J Gastroenterol. 2015;110:381–390. (quiz 391).

    Article  PubMed  Google Scholar 

  13. Mitchell SL, Shaffer ML, Kiely DK, et al. The study of pathogen resistance and antimicrobial use in dementia: study design and methodology. Arch Gerontol Geriatr. 2013;56:16–22.

    Article  PubMed  Google Scholar 

  14. Mitchell SL, Shaffer ML, Loeb MB, et al. Infection management and multidrug-resistant organisms in nursing home residents with advanced dementia. JAMA Intern Med. 2014;174:1660–1667.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Volicer L, Hurley AC, Lathi DC, et al. Measurement of severity in advanced Alzheimer’s disease. J Gerontol. 1994;49:M223–M226.

    Article  PubMed  CAS  Google Scholar 

  16. Albert M, Cohen C. The Test for Severe Impairment: an instrument for the assessment of patients with severe cognitive dysfunction. J Am Geriatr Soc. 1992;40:449–453.

    Article  PubMed  CAS  Google Scholar 

  17. Caporaso JG, Kuczynski J, Stombaugh J, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 2010;7:335–336.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  18. Iizumi T, Taniguchi T, Yamazaki W, et al. Effect of antibiotic pre-treatment and pathogen challenge on the intestinal microbiota in mice. Gut Pathog. 2016;8:60.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  19. Callahan BJ, McMurdie PJ, Rosen MJ, et al. DADA2: high-resolution sample inference from Illumina amplicon data. Nat Methods. 2016;13:581–583.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  20. McMurdie PJ, Holmes S. phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. PLoS ONE. 2013;8:e61217.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  21. Segata N, Izard J, Waldron L, et al. Metagenomic biomarker discovery and explanation. Genome Biol. 2011;12:R60.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Mitchell SL. Advanced dementia. N Engl J Med. 2015;373:1276–1277.

    PubMed  PubMed Central  Google Scholar 

  23. Claesson MJ, Jeffery IB, Conde S, et al. Gut microbiota composition correlates with diet and health in the elderly. Nature. 2012;488:178–184.

    Article  PubMed  CAS  Google Scholar 

  24. Lewis BB, Pamer EG. Microbiota-based therapies for Clostridium difficile and antibiotic-resistant enteric infections. Annu Rev Microbiol. 2017;71:157–178.

    Article  PubMed  CAS  Google Scholar 

  25. Antharam VC, Li EC, Ishmael A, et al. Intestinal dysbiosis and depletion of butyrogenic bacteria in Clostridium difficile infection and nosocomial diarrhea. J Clin Microbiol. 2013;51:2884–2892.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Kim S, Covington A, Pamer EG. The intestinal microbiota: antibiotics, colonization resistance, and enteric pathogens. Immunol Rev. 2017;279:90–105.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  27. D’Agata E, Mitchell SL. Patterns of antimicrobial use among nursing home residents with advanced dementia. Arch Intern Med. 2008;168:357–362.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Lee YJ, Arguello ES, Jenq RR, et al. Protective factors in the intestinal microbiome against Clostridium difficile infection in recipients of allogeneic hematopoietic stem cell transplantation. J Infect Dis. 2017;215:1117–1123.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Lawley TD, Walker AW. Intestinal colonization resistance. Immunology. 2013;138:1–11.

    Article  PubMed  CAS  Google Scholar 

  30. Schubert AM, Rogers MA, Ring C, et al. Microbiome data distinguish patients with Clostridium difficile infection and non-C. difficile-associated diarrhea from healthy controls. MBio. 2014;5:e01021-01014.

    Article  CAS  Google Scholar 

  31. Zhang L, Dong D, Jiang C, et al. Insight into alteration of gut microbiota in Clostridium difficile infection and asymptomatic C. difficile colonization. Anaerobe. 2015;34:1–7.

    Article  PubMed  CAS  Google Scholar 

  32. Milani C, Ticinesi A, Gerritsen J, et al. Gut microbiota composition and Clostridium difficile infection in hospitalized elderly individuals: a metagenomic study. Sci Rep. 2016;6:25945.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  33. Rea MC, O’Sullivan O, Shanahan F, et al. Clostridium difficile carriage in elderly subjects and associated changes in the intestinal microbiota. J Clin Microbiol. 2012;50:867–875.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  34. Chang JY, Antonopoulos DA, Kalra A, et al. Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea. J Infect Dis. 2008;197:435–438.

    Article  PubMed  Google Scholar 

  35. Bassis CM, Moore NM, Lolans K, et al. Comparison of stool versus rectal swab samples and storage conditions on bacterial community profiles. BMC Microbiol. 2017;17:78.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Budding AE, Grasman ME, Eck A, et al. Rectal swabs for analysis of the intestinal microbiota. PLoS ONE. 2014;9:e101344.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

Download references

Funding

This work has been supported by the National Institute of Allergy and Infectious Diseases (K24 AI119158 [EMCD]), the Centers for Disease Control and Prevention’s investments to combat antibiotic resistance under Award Number 200-2016-91939 (EMCD and RA), NIH-NIA R01 AG032982 (SM, EMCD), and NIH-NIA K24AG033640 (SM).

Author information

Authors and Affiliations

  1. Instituto de Ciencias e Innovación en Medicina (ICIM), Facultad de Medicina Clínica Alemana, Universidad del Desarrollo, Santiago, Chile

    Rafael Araos

  2. Infectious Diseases Division, Rhode Island Hospital, Warren Alpert Medical School of Brown University, 593 Eddy Street, Aldrich 720, Providence, RI, USA

    Nikolaos Andreatos, Eleftherios Mylonakis & Erika M. C. D’Agata

  3. uBiome, Inc, San Francisco, CA, USA

    Juan Ugalde

  4. Centro de Bioinformatica y Biología Integrativa, Facultad de Ciencias Biológicas, Universidad Andrés Bello, Santiago, Chile

    Juan Ugalde

  5. Hebrew SeniorLife Institute for Aging Research, Boston, MA, USA

    Susan Mitchell

Authors
  1. Rafael Araos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nikolaos Andreatos
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Juan Ugalde
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Susan Mitchell
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Eleftherios Mylonakis
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Erika M. C. D’Agata
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Dr. D’Agata and Araos contributed to the study concept and design, acquisition of subjects, and collection of the relevant data. Dr. Araos, Ugalde, and D’Agata performed the data analysis. All authors contributed to data interpretation and collaborated on the drafting and revision of the manuscript. Dr. Araos is the guarantor and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Corresponding author

Correspondence to Erika M. C. D’Agata.

Ethics declarations

Conflict of interest

Juan Ugalde is an employee of uBiome Inc and has received stock options as well as other compensation.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Araos, R., Andreatos, N., Ugalde, J. et al. Fecal Microbiome Among Nursing Home Residents with Advanced Dementia and Clostridium difficile. Dig Dis Sci 63, 1525–1531 (2018). https://doi.org/10.1007/s10620-018-5030-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-018-5030-7

Keywords

  • Microbiome
  • Advanced dementia
  • Colonization
  • Clostridium difficile